Study highlights the significant enhancement in predicting common diseases like heart disease, diabetes, Alzheimer’s, and prostate cancer by integrating polygenic risk scores (PRSs) and gut microbiome scores with conventional risk factors, showcasing the potential of multiomic approaches in personalized medicine.
What’s New in Targeted Lung Cancer Treatment?
MedPage Today brought together three expert leaders for a virtual roundtable discussion on lung cancer: Moderator Roy Herbst, MD, PhD, is joined by Anne Chiang,